Recall archive / FDA drug enforcement
Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. T... — FDA record D-0569-2022
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Feb 14, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple Terrace, FL 33637 (813) 901-6392
- Reason
- Subpotent drug
- Classification
- Class III
- Recalling firm
- BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy
- Quantity
- 1157 bags
- Agency-reported status
- Terminated
- Source record identifier
- D-0569-2022
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot #: Nore1620220111, Nore1620220113, Nore1620220118, Nore1620220125, Nore1620220127, Nore1620220202, Exp 3/31/22 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Florida
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Mar 2, 2022
- Recall initiation date
- Feb 14, 2022
- Center classification date
- Feb 18, 2022
- Termination date
- Dec 8, 2022
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.